Vivos Therapeutics (VVOS) Q2 2025 Earnings

15MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-1.63
-1.22
-0.81
-0.4

Details

Expected EPS
-0.4
Actual EPS
-0.45
Surprise EPS
-0.05
Surprise Percent
+12.5%

Description

Vivos Therapeutics (VVOS) has reported earnings of -0.45 per share for Q2 2025.

0 Comments

Share your thoughts